Katherine Frost King, AA-C - Medicare Anesthesiology Assistant in Atlanta, GA

Katherine Frost King, AA-C is a medicare enrolled "Anesthesiologist Assistant" in Atlanta, Georgia. She graduated from nursing school in 2006 and has 18 years of diverse experience with area of expertise as Anesthesiology Assistant. She is a member of the group practice Emory Specialty Associates, Llc and her current practice location is 1000 Johnson Ferry Rd Ne, Atlanta, Georgia. You can reach out to her office (for appointments etc.) via phone at (770) 645-9181.

Katherine Frost King is licensed to practice in Georgia (license number 4903) and she also participates in the medicare program. She may accept medicare assignments (which means she may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance) and her NPI Number is 1164512307.

Contact Information

Katherine Frost King, AA-C
1000 Johnson Ferry Rd Ne,
Atlanta, GA 30342-1606
(770) 645-9181
(770) 645-8455



Provider's Profile

Full NameKatherine Frost King
GenderFemale
SpecialityAnesthesiology Assistant
Experience18 Years
Location1000 Johnson Ferry Rd Ne, Atlanta, Georgia
Accepts Medicare AssignmentsMay be. She may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Katherine Frost King graduated from nursing school in 2006
  NPI Data:
  • NPI Number: 1164512307
  • Provider Enumeration Date: 10/16/2006
  • Last Update Date: 04/05/2022
  Medicare PECOS Information:
  • PECOS PAC ID: 9931291390
  • Enrollment ID: I20070815000690

Medical Identifiers

Medical identifiers for Katherine Frost King such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1164512307NPI-NPPES
4903OtherGAPHYSICIAN ASST LIC NO.
769OtherGANCCAA CERTIFICATION NUMBE

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
367H00000XAnesthesiologist Assistant 4903 (Georgia)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Emory Decatur HospitalDecatur, GAHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Emory Specialty Associates, Llc3476559782430

News Archive

'Navigators' to play pivotal role helping consumers sign up for health insurance

Roll Call reports that many of the people who sign up for insurance through the exchange might face language barriers or may never have had coverage before. Also, CQ HealthBeat reports that web-based insurance brokers want "a place at the table."

EmSense releases new EmBand 24 neuromarketing measurement device

EmSense Corporation, the company that created the first scalable electroencephalography brainwave measurement technology, today announced the addition of the EmBand 24™ to the EmBand™ family of neuromarketing measurement devices.

Abbott, St. Jude Medical enter multi-year joint initiative for cardiovascular treatment technologies

Abbott and St. Jude Medical today announced Choice Alliance, a multi-year joint initiative that provides mutual U.S. customers access to a robust portfolio of interventional cardiology, cardiac rhythm management, electrophysiology and intravascular imaging and diagnostic technologies.

New analyses of long-term LIALDA (mesalamine) data presented at ACG

Post-hoc and other analyses of secondary endpoints of a long-term safety and tolerability study of Shire plc's ulcerative colitis (UC) drug LIALDA (mesalamine) provide further data on LIALDA in patients with mild to moderate ulcerative colitis.

Study identifies small molecule inhibitors of SARS-CoV-2 which block key cellular kinases

Antiviral drug screen of kinase inhibitors, which was done by researchers from the University of California and Cedars-Sinai Medical Center, identified cellular signaling pathways critical for SARS-CoV-2 replication and revealed an important mechanism of host-pathogen interaction vital for further drug research. Their results are available on the bioRxiv* preprint server.

Read more Medical News

› Verified 8 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Katherine Frost King allows following entities to bill medicare on her behalf.
Entity NameEmory Specialty Associates, Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1407864168
PECOS PAC ID: 3476559782
Enrollment ID: O20061010000447

News Archive

'Navigators' to play pivotal role helping consumers sign up for health insurance

Roll Call reports that many of the people who sign up for insurance through the exchange might face language barriers or may never have had coverage before. Also, CQ HealthBeat reports that web-based insurance brokers want "a place at the table."

EmSense releases new EmBand 24 neuromarketing measurement device

EmSense Corporation, the company that created the first scalable electroencephalography brainwave measurement technology, today announced the addition of the EmBand 24™ to the EmBand™ family of neuromarketing measurement devices.

Abbott, St. Jude Medical enter multi-year joint initiative for cardiovascular treatment technologies

Abbott and St. Jude Medical today announced Choice Alliance, a multi-year joint initiative that provides mutual U.S. customers access to a robust portfolio of interventional cardiology, cardiac rhythm management, electrophysiology and intravascular imaging and diagnostic technologies.

New analyses of long-term LIALDA (mesalamine) data presented at ACG

Post-hoc and other analyses of secondary endpoints of a long-term safety and tolerability study of Shire plc's ulcerative colitis (UC) drug LIALDA (mesalamine) provide further data on LIALDA in patients with mild to moderate ulcerative colitis.

Study identifies small molecule inhibitors of SARS-CoV-2 which block key cellular kinases

Antiviral drug screen of kinase inhibitors, which was done by researchers from the University of California and Cedars-Sinai Medical Center, identified cellular signaling pathways critical for SARS-CoV-2 replication and revealed an important mechanism of host-pathogen interaction vital for further drug research. Their results are available on the bioRxiv* preprint server.

Read more Medical News

› Verified 8 days ago

Entity NameGrady Memorial Hospital Corporation
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1114243813
PECOS PAC ID: 7517032998
Enrollment ID: O20100723000311

News Archive

'Navigators' to play pivotal role helping consumers sign up for health insurance

Roll Call reports that many of the people who sign up for insurance through the exchange might face language barriers or may never have had coverage before. Also, CQ HealthBeat reports that web-based insurance brokers want "a place at the table."

EmSense releases new EmBand 24 neuromarketing measurement device

EmSense Corporation, the company that created the first scalable electroencephalography brainwave measurement technology, today announced the addition of the EmBand 24™ to the EmBand™ family of neuromarketing measurement devices.

Abbott, St. Jude Medical enter multi-year joint initiative for cardiovascular treatment technologies

Abbott and St. Jude Medical today announced Choice Alliance, a multi-year joint initiative that provides mutual U.S. customers access to a robust portfolio of interventional cardiology, cardiac rhythm management, electrophysiology and intravascular imaging and diagnostic technologies.

New analyses of long-term LIALDA (mesalamine) data presented at ACG

Post-hoc and other analyses of secondary endpoints of a long-term safety and tolerability study of Shire plc's ulcerative colitis (UC) drug LIALDA (mesalamine) provide further data on LIALDA in patients with mild to moderate ulcerative colitis.

Study identifies small molecule inhibitors of SARS-CoV-2 which block key cellular kinases

Antiviral drug screen of kinase inhibitors, which was done by researchers from the University of California and Cedars-Sinai Medical Center, identified cellular signaling pathways critical for SARS-CoV-2 replication and revealed an important mechanism of host-pathogen interaction vital for further drug research. Their results are available on the bioRxiv* preprint server.

Read more Medical News

› Verified 8 days ago

Entity NameMak Anesthesia Cobb Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1699045070
PECOS PAC ID: 7810154960
Enrollment ID: O20120201000868

News Archive

'Navigators' to play pivotal role helping consumers sign up for health insurance

Roll Call reports that many of the people who sign up for insurance through the exchange might face language barriers or may never have had coverage before. Also, CQ HealthBeat reports that web-based insurance brokers want "a place at the table."

EmSense releases new EmBand 24 neuromarketing measurement device

EmSense Corporation, the company that created the first scalable electroencephalography brainwave measurement technology, today announced the addition of the EmBand 24™ to the EmBand™ family of neuromarketing measurement devices.

Abbott, St. Jude Medical enter multi-year joint initiative for cardiovascular treatment technologies

Abbott and St. Jude Medical today announced Choice Alliance, a multi-year joint initiative that provides mutual U.S. customers access to a robust portfolio of interventional cardiology, cardiac rhythm management, electrophysiology and intravascular imaging and diagnostic technologies.

New analyses of long-term LIALDA (mesalamine) data presented at ACG

Post-hoc and other analyses of secondary endpoints of a long-term safety and tolerability study of Shire plc's ulcerative colitis (UC) drug LIALDA (mesalamine) provide further data on LIALDA in patients with mild to moderate ulcerative colitis.

Study identifies small molecule inhibitors of SARS-CoV-2 which block key cellular kinases

Antiviral drug screen of kinase inhibitors, which was done by researchers from the University of California and Cedars-Sinai Medical Center, identified cellular signaling pathways critical for SARS-CoV-2 replication and revealed an important mechanism of host-pathogen interaction vital for further drug research. Their results are available on the bioRxiv* preprint server.

Read more Medical News

› Verified 8 days ago

Entity NameMak Anesthesia, Nw Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1609202720
PECOS PAC ID: 4880820315
Enrollment ID: O20131111001715

News Archive

'Navigators' to play pivotal role helping consumers sign up for health insurance

Roll Call reports that many of the people who sign up for insurance through the exchange might face language barriers or may never have had coverage before. Also, CQ HealthBeat reports that web-based insurance brokers want "a place at the table."

EmSense releases new EmBand 24 neuromarketing measurement device

EmSense Corporation, the company that created the first scalable electroencephalography brainwave measurement technology, today announced the addition of the EmBand 24™ to the EmBand™ family of neuromarketing measurement devices.

Abbott, St. Jude Medical enter multi-year joint initiative for cardiovascular treatment technologies

Abbott and St. Jude Medical today announced Choice Alliance, a multi-year joint initiative that provides mutual U.S. customers access to a robust portfolio of interventional cardiology, cardiac rhythm management, electrophysiology and intravascular imaging and diagnostic technologies.

New analyses of long-term LIALDA (mesalamine) data presented at ACG

Post-hoc and other analyses of secondary endpoints of a long-term safety and tolerability study of Shire plc's ulcerative colitis (UC) drug LIALDA (mesalamine) provide further data on LIALDA in patients with mild to moderate ulcerative colitis.

Study identifies small molecule inhibitors of SARS-CoV-2 which block key cellular kinases

Antiviral drug screen of kinase inhibitors, which was done by researchers from the University of California and Cedars-Sinai Medical Center, identified cellular signaling pathways critical for SARS-CoV-2 replication and revealed an important mechanism of host-pathogen interaction vital for further drug research. Their results are available on the bioRxiv* preprint server.

Read more Medical News

› Verified 8 days ago

Entity NameMak Anesthesia Decatur Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1720409147
PECOS PAC ID: 8224261433
Enrollment ID: O20140423001687

News Archive

'Navigators' to play pivotal role helping consumers sign up for health insurance

Roll Call reports that many of the people who sign up for insurance through the exchange might face language barriers or may never have had coverage before. Also, CQ HealthBeat reports that web-based insurance brokers want "a place at the table."

EmSense releases new EmBand 24 neuromarketing measurement device

EmSense Corporation, the company that created the first scalable electroencephalography brainwave measurement technology, today announced the addition of the EmBand 24™ to the EmBand™ family of neuromarketing measurement devices.

Abbott, St. Jude Medical enter multi-year joint initiative for cardiovascular treatment technologies

Abbott and St. Jude Medical today announced Choice Alliance, a multi-year joint initiative that provides mutual U.S. customers access to a robust portfolio of interventional cardiology, cardiac rhythm management, electrophysiology and intravascular imaging and diagnostic technologies.

New analyses of long-term LIALDA (mesalamine) data presented at ACG

Post-hoc and other analyses of secondary endpoints of a long-term safety and tolerability study of Shire plc's ulcerative colitis (UC) drug LIALDA (mesalamine) provide further data on LIALDA in patients with mild to moderate ulcerative colitis.

Study identifies small molecule inhibitors of SARS-CoV-2 which block key cellular kinases

Antiviral drug screen of kinase inhibitors, which was done by researchers from the University of California and Cedars-Sinai Medical Center, identified cellular signaling pathways critical for SARS-CoV-2 replication and revealed an important mechanism of host-pathogen interaction vital for further drug research. Their results are available on the bioRxiv* preprint server.

Read more Medical News

› Verified 8 days ago

Entity NameMak Anesthesia Tch, Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1730549676
PECOS PAC ID: 5890092910
Enrollment ID: O20160404001912

News Archive

'Navigators' to play pivotal role helping consumers sign up for health insurance

Roll Call reports that many of the people who sign up for insurance through the exchange might face language barriers or may never have had coverage before. Also, CQ HealthBeat reports that web-based insurance brokers want "a place at the table."

EmSense releases new EmBand 24 neuromarketing measurement device

EmSense Corporation, the company that created the first scalable electroencephalography brainwave measurement technology, today announced the addition of the EmBand 24™ to the EmBand™ family of neuromarketing measurement devices.

Abbott, St. Jude Medical enter multi-year joint initiative for cardiovascular treatment technologies

Abbott and St. Jude Medical today announced Choice Alliance, a multi-year joint initiative that provides mutual U.S. customers access to a robust portfolio of interventional cardiology, cardiac rhythm management, electrophysiology and intravascular imaging and diagnostic technologies.

New analyses of long-term LIALDA (mesalamine) data presented at ACG

Post-hoc and other analyses of secondary endpoints of a long-term safety and tolerability study of Shire plc's ulcerative colitis (UC) drug LIALDA (mesalamine) provide further data on LIALDA in patients with mild to moderate ulcerative colitis.

Study identifies small molecule inhibitors of SARS-CoV-2 which block key cellular kinases

Antiviral drug screen of kinase inhibitors, which was done by researchers from the University of California and Cedars-Sinai Medical Center, identified cellular signaling pathways critical for SARS-CoV-2 replication and revealed an important mechanism of host-pathogen interaction vital for further drug research. Their results are available on the bioRxiv* preprint server.

Read more Medical News

› Verified 8 days ago

Entity NameMak Anesthesia Holdings, Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1912452939
PECOS PAC ID: 4284917204
Enrollment ID: O20170216001563

News Archive

'Navigators' to play pivotal role helping consumers sign up for health insurance

Roll Call reports that many of the people who sign up for insurance through the exchange might face language barriers or may never have had coverage before. Also, CQ HealthBeat reports that web-based insurance brokers want "a place at the table."

EmSense releases new EmBand 24 neuromarketing measurement device

EmSense Corporation, the company that created the first scalable electroencephalography brainwave measurement technology, today announced the addition of the EmBand 24™ to the EmBand™ family of neuromarketing measurement devices.

Abbott, St. Jude Medical enter multi-year joint initiative for cardiovascular treatment technologies

Abbott and St. Jude Medical today announced Choice Alliance, a multi-year joint initiative that provides mutual U.S. customers access to a robust portfolio of interventional cardiology, cardiac rhythm management, electrophysiology and intravascular imaging and diagnostic technologies.

New analyses of long-term LIALDA (mesalamine) data presented at ACG

Post-hoc and other analyses of secondary endpoints of a long-term safety and tolerability study of Shire plc's ulcerative colitis (UC) drug LIALDA (mesalamine) provide further data on LIALDA in patients with mild to moderate ulcerative colitis.

Study identifies small molecule inhibitors of SARS-CoV-2 which block key cellular kinases

Antiviral drug screen of kinase inhibitors, which was done by researchers from the University of California and Cedars-Sinai Medical Center, identified cellular signaling pathways critical for SARS-CoV-2 replication and revealed an important mechanism of host-pathogen interaction vital for further drug research. Their results are available on the bioRxiv* preprint server.

Read more Medical News

› Verified 8 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Katherine Frost King is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Katherine Frost King, AA-C
3155 N Point Pkwy, Building F, Suite 100,
Alpharetta, GA 30005-5481

Ph: (770) 645-9181
Katherine Frost King, AA-C
1000 Johnson Ferry Rd Ne,
Atlanta, GA 30342-1606

Ph: (770) 645-9181

News Archive

'Navigators' to play pivotal role helping consumers sign up for health insurance

Roll Call reports that many of the people who sign up for insurance through the exchange might face language barriers or may never have had coverage before. Also, CQ HealthBeat reports that web-based insurance brokers want "a place at the table."

EmSense releases new EmBand 24 neuromarketing measurement device

EmSense Corporation, the company that created the first scalable electroencephalography brainwave measurement technology, today announced the addition of the EmBand 24™ to the EmBand™ family of neuromarketing measurement devices.

Abbott, St. Jude Medical enter multi-year joint initiative for cardiovascular treatment technologies

Abbott and St. Jude Medical today announced Choice Alliance, a multi-year joint initiative that provides mutual U.S. customers access to a robust portfolio of interventional cardiology, cardiac rhythm management, electrophysiology and intravascular imaging and diagnostic technologies.

New analyses of long-term LIALDA (mesalamine) data presented at ACG

Post-hoc and other analyses of secondary endpoints of a long-term safety and tolerability study of Shire plc's ulcerative colitis (UC) drug LIALDA (mesalamine) provide further data on LIALDA in patients with mild to moderate ulcerative colitis.

Study identifies small molecule inhibitors of SARS-CoV-2 which block key cellular kinases

Antiviral drug screen of kinase inhibitors, which was done by researchers from the University of California and Cedars-Sinai Medical Center, identified cellular signaling pathways critical for SARS-CoV-2 replication and revealed an important mechanism of host-pathogen interaction vital for further drug research. Their results are available on the bioRxiv* preprint server.

Read more News

› Verified 8 days ago


Anesthesiologist Assistant Nurses in Atlanta, GA

Matthew Lewis, PAA
Anesthesiologist Assistant
Medicare: Medicare Enrolled
Practice Location: 1405 Clifton Rd Ne Fl 3, Atlanta, GA 30322
Phone: 404-785-6670    Fax: 404-785-1362
Elizabeth Ikeda,
Anesthesiologist Assistant
Medicare: Medicare Enrolled
Practice Location: 1365 Clifton Rd Ne, Atlanta, GA 30322
Phone: 404-778-8311    
Amar R Herndon,
Anesthesiologist Assistant
Medicare: Medicare Enrolled
Practice Location: 1000 Johnson Ferry Rd Ne, Atlanta, GA 30342
Phone: 770-645-9181    
Shelley S Staton, PAAA
Anesthesiologist Assistant
Medicare: Medicare Enrolled
Practice Location: 1000 Johnson Ferry Rd, Atlanta, GA 30342
Phone: 770-645-9181    Fax: 770-645-8455
Mr. Grant Michael Mury, PAA
Anesthesiologist Assistant
Medicare: Accepting Medicare Assignments
Practice Location: 550 Peachtree St Ne, Atlanta, GA 30308
Phone: 404-778-3900    
Ashley Schade, PAAA
Anesthesiologist Assistant
Medicare: Accepting Medicare Assignments
Practice Location: 5665 Peachtree Dunwoody Rd, Atlanta, GA 30342
Phone: 706-543-3449    
Jiaqi Tracy Li, PAA
Anesthesiologist Assistant
Medicare: Medicare Enrolled
Practice Location: 1001 Johnson Fy Rd Ne, Atlanta, GA 30342
Phone: 404-785-2008    Fax: 404-785-4496

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.